Category Archives: Uncategorized

  • Potential pregnancy

If there is any reason to believe that the woman may already have an established pregnancy, she should be referred to a doctor1

ellaOne® is not intended for use during pregnancy and should not be taken by any woman suspected or known to be pregnant.1

However, ellaOne® does not interrupt an existing pregnancy

Women may believe they are pregnant from the moment of unprotected sex, so asking “Could you be pregnant?” is unhelpful.
More specific questions e.g. “Is your menstrual period due or late?” will be more helpful. If the woman’s period is late, or in case of symptoms of pregnancy, she should do a pregnancy test or be referred to a doctor before taking ellaOne.

  • ellaOne® does not prevent pregnancy in every case.

If the woman’s next menstrual period is more than 7 days late, or abnormal in
character, or if there are symptoms suggestive of pregnancy, or in case of
doubt, a pregnancy test should be performed. It is important that any pregnancy
in a woman who has taken ellaOne® be reported to The purpose of this web-based registry is to collect safety information from women who have taken ellaOne® during pregnancy or who become pregnant after ellaOne® intake. All patient data collected will remain anonymous.

Pregnancy registry

  • ellaOne® is for occasional use only.

It should in no instance replace a regular contraceptive method. In any case, women should be advised to adopt a regular method of contraception.

  • After using ellaOne®, women should be advised to use a reliable barrier method until their next menstrual period.

If a woman wishes to initiate or continue using hormonal contraception, she can do so after using ellaOne®, however she should be advised to use a reliable barrier method until her next menstrual period.




1.ellaOne ® European Union Summary of Product Characteristics

As with any drug, ellaOne® has some contraindications. ellaOne® should not be taken by women who:

• Are hypersensitive to the active substance or to any of the excipients1

Always refer to the ellaOne® product information if you are in any doubt.

Situations where ellaOne® is not recommended

• Severe asthma treated by oral glucocorticoids1

• Severe hepatic impairment1

• For women taking CYP3A4 inducers1

• Concomitant use of EC containing levonorgestrel1

• ellaOne® contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.

• Breastfeeding is not recommended for one week after ellaOne® intake1


1.ellaOne® European Union Summary of Product Characteristics.

ellaOne® (30mg ulipristal acetate) is an emergency contraceptive pill (ECP), now available in pharmacy without a prescription in the EU. 

The OTC availability of emergency contraceptive pills is critical to increase access and minimise any delay in taking them. This is especially significant given that emergency contraceptive pills are more effective the sooner they are taken after unprotected intercourse.

The advice of pharmacy staff and emergency contraceptive efficacy are the two most important factors in the choice of emergency contraceptive pill.1

This website has been developed to help you learn more about ellaOne®. This website is for healthcare professionals only. It is aimed at community pharmacists, pharmacy assistants and anyone in the pharmacy team who may dispense emergency contraception.

It will help you make responsible, confident recommendations and give appropriate advice to women requesting emergency contraception in your pharmacy.


It will also help you give appropriate counselling on ellaOne® as well as subsequent contraceptive care, to support the best health outcomes.

1.HRA Data on File. Harris Interactive 2013.